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INTRODUCTION & OBJECTIVES: Polypropylene mesh for pelvic floor surgery is 
associated with serious complications ( e.g. erosion). A biodegradable tissue 
engineered mesh composed of a polylactic acid (PLA) scaffold seeded with 
autologous cells is a promising alternative. However, thus far elastin content 
(important for elastic recoil) in this tissue has been low. We aimed to increase 
elastin expression and test the resultant tensile properties. 
MATERIAL & METHODS: Oral fibroblasts were isolated from oral mucosa biopsies 
taken with consent and ethical approval. PLA electrospun scaffolds were seeded 
with 500,000 cells and placed into 6-well plates and cultured for 14 days. Media 
was either normal DMEM (control) or DMEM supplemented with either 
dexamethasone (10-5 or 10-9)) or retinoic acid (10-7 or 10-11), media was 
changed 3 times per week. 
RESULTS: Cells proliferated on scaffolds, shown by increased metabolic activity 
(AlamarBlue assay) during the 14 days–this was not influenced by either 
additive. Collagen production (measured by Sirius red assay) was significantly 
increased by dexamethasone at both concentrations but not by retinoic acid 
(Figure 1). Elastin expression, measured by immunofluorescence staining (figure 
2) assessed by blinded observer assessment, was increased by dexamethasone 
and retinoic acid (at both concentrations). While all samples had equivalent 
tensile strength (all > normal paravaginal fascia) dexamethasone resulted in the 
greatest elastic modulus (20.9 and 21.8 MPa for concentrations of 10-5 or 10-9 
M respectively) and had the most confluent extracellular matrix (ECM) on 
scanning electron microscopy (SEM)(figure 2). 
 
 
 
 
  
 
Figure 1: Collagen production (sirus red assay). 
NM= normal media, RA= retinoic acid, Dex= dexamethasone, n=9 ± sem, * = 
significant (p<0.05) difference versus NM. 
 
Figure 2: Representative images for ECM production on SEM(top row) and 
Elastin fibres on immunofluorescence(bottom row) 
 
 
CONCLUSIONS: Dexamethasone (10-5 or 10-9 M) was a useful additive for the 
culture of oral fibroblasts on PLA scaffolds improving the production of elastin 
and collagen on the scaffold. Future work will study the effect of subjecting the 
cell-seeded scaffolds to physiological dynamic strain on elastin organization and 
tensile properties. 
